Comparison between Aeroflex Industries IPO and Concord Biotech IPO.
Aeroflex Industries IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Concord Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Aeroflex Industries IPO is up to ₹351.00 Cr whereas the issue size of the Concord Biotech IPO is up to ₹1,550.52 Cr. The final issue price of Aeroflex Industries IPO is ₹108.00 per share and of Concord Biotech IPO is ₹741.00 per share.
| Aeroflex Industries IPO | Concord Biotech IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹102.00 per share | ₹705.00 per share |
| Issue Price (Upper) | ₹108.00 per share | ₹741.00 per share |
| Issue Price (Final) | ₹108.00 per share | ₹741.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | |
| Market Lot Size | 130 shares | 20 shares |
| Fresh Issue Size | 1,50,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹162.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,75,00,000 shares | 2,09,25,652 shares |
| OFS Issue Size (Amount) | up to ₹189.00 Cr | up to ₹1,550.52 Cr |
| Issue Size Total | 3,25,00,000 shares | 2,09,25,652 shares |
| Issue Size Total (Amount) | up to ₹351.00 Cr | up to ₹1,550.52 Cr |
Aeroflex Industries IPO opens on Aug 22, 2023, while Concord Biotech IPO opens on Aug 04, 2023. The closing date of Aeroflex Industries IPO and Concord Biotech IPO is Aug 24, 2023, and Aug 08, 2023, respectively.
| Aeroflex Industries IPO | Concord Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Aug 21, 2023 | Aug 03, 2023 |
| Issue Open | Aug 22, 2023 | Aug 04, 2023 |
| Issue Close | Aug 24, 2023 | Aug 08, 2023 |
| Basis Of Allotment (Tentative) | Aug 29, 2023 | Aug 11, 2023 |
| Initiation of Refunds (Tentative) | Aug 30, 2023 | Aug 14, 2023 |
| Credit of Share (Tentative) | Aug 31, 2023 | Aug 17, 2023 |
| Listing date (Tentative) | Aug 31, 2023 | Aug 18, 2023 |
| Anchor Lockin End date 1 | Sep 28, 2023 | Sep 10, 2023 |
| Anchor Lockin End date 2 | Nov 27, 2023 | Nov 09, 2023 |
Aeroflex Industries IPO P/E ratio is 40.91, as compared to Concord Biotech IPO P/E ratio of 32.29.
| Aeroflex Industries IPO | Concord Biotech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.09 | 44.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.99 | 44.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 40.91 | 32.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1396.66 Cr. | ₹7752.06 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 26.43% | 20.06% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 31.96% | 24.27% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.64 | ₹20.79 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.43% | 20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aeroflex Industries IPO Retail Individual Investors (RII) are offered 1,12,00,000 shares while in Concord Biotech IPO retail investors are offered 1,12,00,000 shares. Qualified Institutional Buyers (QIB) are offered 64,00,020 shares in Aeroflex Industries IPO and 41,83,130 shares in Concord Biotech IPO.
| Aeroflex Industries IPO | Concord Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 95,99,980 shares | 62,74,695 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 64,00,020 shares | 41,83,130 shares |
| NII | 48,00,000 shares | 31,37,348 shares |
| RII | 1,12,00,000 shares | 73,20,479 shares |
| Employee | 0 shares | 10,000 shares |
| Others | ||
| Total | 3,25,00,000 shares | 2,09,25,652 shares |
Aeroflex Industries IPO subscribed 97.11x in total, whereas Concord Biotech IPO subscribed 24.87x.
| Aeroflex Industries IPO | Concord Biotech IPO | |
|---|---|---|
| QIB (times) | 194.73x | 67.67x |
| NII (times) | 126.13x | 16.99x |
| Big NII (times) | 125.80x | 19.30x |
| Small NII (times) | 126.80x | 12.37x |
| RII (times) | 34.41x | 3.78x |
| Employee (times) | 24.48x | |
| Other (times) | 28.52x | |
| Total (times) | 97.11x | 24.87x |
